These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1570391)

  • 1. Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study.
    Foulds J; Stapleton J; Feyerabend C; Vesey C; Jarvis M; Russell MA
    Psychopharmacology (Berl); 1992; 106(3):421-7. PubMed ID: 1570391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L; Busto UE; MacDonald A; Corrigall WA
    Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting smoking cessation. Who will quit with and without the nicotine patch.
    Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
    JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine.
    Benowitz NL; Zevin S; Jacob P
    J Pharmacol Exp Ther; 1998 Dec; 287(3):958-62. PubMed ID: 9864279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.
    Donny EC; Jones M
    Drug Alcohol Depend; 2009 Sep; 104(1-2):23-33. PubMed ID: 19446968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precessation treatment with nicotine skin patch facilitates smoking cessation.
    Rose JE; Behm FM; Westman EC; Kukovich P
    Nicotine Tob Res; 2006 Feb; 8(1):89-101. PubMed ID: 16497603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking Topography Characteristics of Very Low Nicotine Content Cigarettes, With and Without Nicotine Replacement, in Smokers With Schizophrenia and Controls.
    Tidey JW; Cassidy RN; Miller ME
    Nicotine Tob Res; 2016 Sep; 18(9):1807-12. PubMed ID: 26995794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varying nicotine patch dose and type of smoking cessation counseling.
    Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
    JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
    Yudkin PL; Jones L; Lancaster T; Fowler GH
    Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation.
    Perng RP; Hsieh WC; Chen YM; Lu CC; Chiang SJ
    J Formos Med Assoc; 1998 Aug; 97(8):547-51. PubMed ID: 9747065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial.
    Foulds J; Stapleton J; Hayward M; Russell MA; Feyerabend C; Fleming T; Costello J
    Arch Fam Med; 1993 Apr; 2(4):417-23. PubMed ID: 8130921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia.
    Dalack GW; Meador-Woodruff JH
    Nicotine Tob Res; 1999 Mar; 1(1):53-7. PubMed ID: 11072388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal nicotine: reduction of smoking with minimal abuse liability.
    Pickworth WB; Bunker EB; Henningfield JE
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):9-14. PubMed ID: 7862918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Trial of Low-Nicotine Cigarettes and Transdermal Nicotine.
    Smith TT; Koopmeiners JS; Tessier KM; Davis EM; Conklin CA; Denlinger-Apte RL; Lane T; Murphy SE; Tidey JW; Hatsukami DK; Donny EC
    Am J Prev Med; 2019 Oct; 57(4):515-524. PubMed ID: 31542129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.
    Levin ED; Westman EC; Stein RM; Carnahan E; Sanchez M; Herman S; Behm FM; Rose JE
    J Clin Psychopharmacol; 1994 Feb; 14(1):41-9. PubMed ID: 8151002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of payment for reduced carbon monoxide levels and noncontingent payments on smoking behaviors in cocaine-abusing outpatients wearing nicotine or placebo patches.
    Wiseman EJ; Williams DK; McMillan DE
    Exp Clin Psychopharmacol; 2005 May; 13(2):102-10. PubMed ID: 15943543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transdermal nicotine patch: results of a randomised placebo-controlled trial.
    Richmond RL; Harris K; de Almeida Neto A
    Med J Aust; 1994 Jul; 161(2):130-5. PubMed ID: 8028537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.